STOCK TITAN

ATRENEW INC Form 4 Filings

RERE NYSE

Every Form 4 that ATRENEW INC (RERE) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow RERE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RERE filings page.

Rhea-AI Summary

ATRenew Inc. (RERE) reported that its Chief Financial Officer, Chen Chen, received multiple option grants on Class A ordinary shares. On 2026-08-18, Chen was granted options to acquire a total of 91,643 shares at an exercise price of $0.10 per share, with exercise dates in 2026–2027 and expirations in 2035–2036.

Rhea-AI Summary

ATRenew Inc. (RERE) reported that Executive President and director Wang Yongliang received several option grants on 2026-08-18. These options give the right to buy Class A ordinary shares at an exercise price of $0.10 per share, with exercise dates ranging from 2025-07-01 to 2027-04-01 and expirations between 2035 and 2036.

Rhea-AI Summary

ATRenew Inc. director Wang Jingbo reported acquiring additional equity through the vesting and exercise of equity awards. On June 18, 2026, 15,000 American depositary shares (ADSs) were acquired upon vesting of restricted share units, bringing Wang’s direct holdings to 68,250 ADSs. Each three ADSs represent two Class A ordinary shares. On the same date, 10,000 restricted share units tied to 10,000 Class A ordinary shares remained outstanding from a 30,000-share grant that vests in three equal annual installments through continued service.

Rhea-AI Summary

ATRenew Inc. director Zhu Rui reported both a sale and equity award activity involving the company’s American depositary shares (ADS) and restricted share units (RSUs). Zhu sold 4,762 ADS in an open-market transaction at $4.00 per ADS and held 55,238 ADS directly afterward. On the same date, 10,000 RSUs vested and converted into Class A ordinary shares, corresponding to 15,000 ADS acquired at no cash cost, reflecting equity compensation rather than a cash purchase. Following the vesting, Zhu still holds 20,000 RSUs tied to Class A ordinary shares, which are scheduled to vest in two further annual installments, subject to continued service.

Rhea-AI Summary

ATRenew Inc.’s Chief Executive Officer Kerry Xuefeng Chen exercised options and restricted share units into Class A ordinary shares on March 25, 2026, then received 8,423,097 American depositary shares as a result of these derivative exercises and vesting events.

Following these transactions, he directly holds 9,134,518 ADS. He also indirectly holds 11,287,336 Class C ordinary shares through C&XF Group Limited, which is wholly owned by him. The filing reports 5,615,398 derivative shares exercised in total and shows no open-market sales.

Rhea-AI Summary

ATRenew Inc. director Wang Jingbo reported equity compensation vesting rather than open-market trading. On March 25, 2026, Wang exercised restricted share units covering 16,500, 9,000, and 10,000 Class A ordinary shares, each at an exercise price of $0.00 per share.

These awards were originally granted in 2021, 2022, and 2024 and vest in annual installments, subject to continued service. Wang also acquired 53,250 American depositary shares through the vesting of restricted share units, with no reported open-market purchases or sales.

Rhea-AI Summary

ATRenew Inc. director Zhu Rui reported equity compensation vesting, not an open-market trade. He exercised 30,000 restricted share units, each representing one Class A ordinary share. In connection with this vesting, he acquired 45,000 American depositary shares, which continue to be held directly after the transaction.